Announcements Trials
Browse Landscape

Phase

Phase 3 2Phase NA 1

Status

Completed 49Active not recruiting 32Recruiting 23Terminated 13Unknown 7Withdrawn 3Not yet recruiting 3Suspended 1

Sponsor Class

OTHER 2NETWORK 1

Study Type

Interventional 3

Sponsor

Cancer Type

Dermatologic 4Thoracic 3Genitourinary 3Gastrointestinal 3Sarcoma 1

Conditions

Carcinoma, Renal Cell 2Clear-cell metastatic renal cell carcinoma 1Advanced Kidney Cancer 1

Interventions

Gemcitabine 13Radiotherapy 12Androgen Antagonists 12Specimen Handling 11Magnetic Resonance Spectroscopy 10pembrolizumab 9Nivolumab 8toripalimab 7darolutamide 7Drug Therapy 7Radiosurgery 6Docetaxel 6Cystectomy 6enzalutamide 5apalutamide 5Mitomycin 5Cisplatin 5Axitinib 5Abiraterone Acetate 5disitamab vedotin 4cabozantinib 4abiraterone 4Pluvicto 4Cyclophosphamide 4tislelizumab 3lenvatinib 3fludarabine 3cemiplimab 3Sunitinib 3Standard of Care 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Not yet recruiting × Ipilimumab × Genitourinary × Clear all
NCT07383441 2026-02-03

Adding Biotherapy or Placebo to Standard Treatment for Advanced Kidney Cancer

SWOG Cancer Research Network

Phase 3 Not yet recruiting
718 enrolled
Genitourinary

Clear-cell metastatic renal cell carcinoma, Carcinoma, Renal Cell

NCT07338981 2026-01-14

The Impact of Time-of-day-Dependent Administration of Nivolumab-Ipilimumab (ICI/ICI) Combination on Overall Survival in Adults With Advanced Kidney Cancer: A Pragmatic Multicenter, Randomized Controlled Trial.

British Columbia Cancer Agency

Phase 3 Not yet recruiting
142 enrolled
Genitourinary

Advanced Kidney Cancer

NCT07233668 2025-12-03

IVE in mRCC

Seoul National University Hospital

Phase NA Not yet recruiting
172 enrolled
Genitourinary

Carcinoma, Renal Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡